Personal information

Russia

Activities

Works (9)

Efficacy of tablet glucocorticoids depending on their starting dose in patients with type 2 amiodarone-induced thyrotoxicosis: a prospective randomized study

Almanac of Clinical Medicine
2024-10-10 | Journal article
Contributors: Alexandra S. Ermolaeva; Valentin V. Fadeev
Source: check_circle
Crossref

Individualized selection of recent glucose monitoring devices for self-management based on competitive features

Pakistan Journal of Medical Sciences
2024-07-31 | Journal article
Part of ISSN: 1681-715X
Part of ISSN: 1682-024X
Contributors: Olga Krylova; Sevara Marchenko; Alexandra Ermolaeva; Natalia Shustikova; Kristina Dyakonova
Source: Self-asserted source
Александра Ермолаева

Type 2 amiodarone-induced thyrotoxicosis: factors of delayed response to glucocorticoid therapy

Clinical and experimental thyroidology
2024-06-11 | Journal article
Contributors: A. S. Ermolaeva; V. V. Fadeev
Source: check_circle
Crossref

Differential diagnosis of amiodarone-induced thyrotoxicosis in a patient with atrial fibrillation and agranulocytosis on the background of thyrostatic therapy. Case report

Consilium Medicum
2024-05-02 | Journal article
Contributors: Kristina Yu. Zherebchikova; Dmitry S. Bubnov; Alexandra S. Ermolaeva; Madina O. Soltakhanova; Yulia P. Sych; Marat V. Ezhov; Valentin V. Fadeev
Source: check_circle
Crossref

Type 2 amiodarone-induced thyrotoxicosis: efficacy of glucocorticoid therapy, a retrospective analysis

Problems of Endocrinology
2024-01-24 | Journal article
Contributors: A. S. Ermolaeva; V. V. Fadeev
Source: check_circle
Crossref

DUOX1 Gene Missense Mutation Confers Susceptibility on Type 2 Amiodarone-Induced Thyrotoxicosis

International Journal of Molecular Sciences
2023 | Journal article
EID:

2-s2.0-85148997603

Part of ISSN: 14220067 16616596
Contributors: Biakina, O.; Mitina, Y.; Gognieva, D.; Axenova, M.; Ermolaeva, A.; Bestavashvili, A.; Fadeev, V.; Syrkin, A.; Kopylov, P.
Source: Self-asserted source
Александра Ермолаева via Scopus - Elsevier
grade
Preferred source (of 2)‎

Type 2 amiodarone-induced thyrotoxicosis: prevalence, time and predictors of development

Problems of Endocrinology
2023-10-23 | Journal article
Contributors: A. S. Ermolaeva; V. V. Fadeev
Source: check_circle
Crossref

Features of the differential diagnosis of thyropathies induced by monoclonal antibodies: a clinical case

Pharmateca
2022-04-16 | Journal article
Part of ISSN: 2414-9128
Contributors: K.Yu. Zherebchikova Zherebchikova; A.S. Ermolaeva Ermolaeva; Yu.P. Sych Sych; V.V. Fadeev Fadeev; I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
Source: Self-asserted source
Александра Ермолаева

Amiodarone-induced thyrotoxicosis type 2: predictors and treatment options

Almanac of Clinical Medicine
2019-05-31 | Journal article
Part of ISSN: 2587-9294
Part of ISSN: 2072-0505
Contributors: A. S. Ermolaeva; O. A. Biakina; J. P. Sytch; P. Yu. Kopylov; V. V. Fadeev
Source: Self-asserted source
Александра Ермолаева